| 崙棫堛栻昳怘昳塹惗尋媶強 |
National Institute of Health Sciences |
| 惗暔栻昳晹 |
Division of Biological Chemistry and Biologicals |
|
丂丂丂 |
亂rINN亃daratumumab (List 63, 2010, Vol.24, No. 1, p49)
亂pINN亃daratumumab (List 101, 2009, Vol.23, No. 2, p138)
亂夝愢乮榓栿乯亃
IgG1內, 峈僸僩ADP-儕儃僔儖僔僋儔乕僛1 (CD38, 僒僀僋儕僢僋ADP-儕儃乕僗僸僪儘儔乕僛1, cADPr 僸僪儘儔乕僛 1,
T10), 僸僩儌僲僋儘乕僫儖峈懱; 峈庮釃栻丏
H嵔 (兞1嵔丆1-452)丗[Homo sapiens VH (IGHV3-23*01 (94.90%) -(IGHD)-IGHJ4*01)
[8.8.15] (1-122) -IGHG1*03 (123-452)]丏
L嵔(內嵔丆1'-214')丗[Homo sapiens VKAPPA (IGKV3-11*01 (100.00%) -IGKJ1*01) [6.3.9]
(1'-107') -IGKC*01 (108'-214')]丏
僕僗儖僼傿僪寢崌偺埵抲丗225-214', 231-231''丆234-234''
摐嵔晅壛埵抲丗302, 302''
亂暘巕幃亃C6466H9996N1724O2010S42
亂CAS斣崋亃945721-28-8
亂JAN亃枹廂嵹
|
|
| Copyright (C) 丂丂丂Division of Biological Chemistry and Biologicals丂丂丂All
rights reserved. |
|
|